1.
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex
by Hysek, Cédric M
Psychopharmacologia, 2012, Vol.224 (3), p.363-376
2.
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
by Williams, Andrea
Nature chemical biology, 2008, Vol.4 (5), p.295-305
3.
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
by ROBBINS, T. W
Psychopharmacologia, 2002, Vol.163 (3-4), p.362-380
4.
Dual contributions of noradrenaline to behavioural flexibility and motivation
by Jahn, Caroline I
Psychopharmacology, 2018, Vol.235 (9), p.2687-2702
5.
Multimodal Perineural Analgesia with Combined Bupivacaine‐Clonidine‐Buprenorphine‐Dexamethasone: Safe In Vivo and Chemically Compatible in Solution
by Williams, Brian A.
Pain medicine (Malden, Mass.), 2015, Vol.16 (1), p.186-198
6.
Clonidine blocks stress-induced craving in cocaine users
by Jobes, Michelle L
Psychopharmacology, 2011, Vol.218 (1), p.83-88
7.
An exploration of the aversive properties of 2-deoxy-D-glucose in rats
by Horman, Thomas
Psychopharmacology, 2018, Vol.235 (10), p.3055-3063
8.
The effects of propranolol and clonidine on bone marrow expression of hematopoietic cytokines following trauma and chronic stress
by Loftus, Tyler J
The American journal of surgery, 2019, Vol.218 (5), p.858-863
9.
Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats
by LE, A. D
Psychopharmacologia, 2005, Vol.179 (2), p.366-373
10.
Clonidine Use in Psychiatry: Panacea or Panache?
by Naguy, Ahmed
Pharmacology, 2016, Vol.98 (1-2), p.87-92
11.
Noradrenergic modulation of risk/reward decision making
by Montes, David R
Psychopharmacology, 2015, Vol.232 (15), p.2681-2696
12.
Noradrenergic and Cholinergic Modulation of Belief Updating
by Jepma, Marieke
Journal of cognitive neuroscience, 2018, Vol.30 (12), p.1803-1820
13.
A Review of the Rationale and Clinical Utilization of α2-Adrenoceptor Agonists for the Treatment of Attention-Deficit/Hyperactivity and Related Disorders
by Sallee, Floyd
Journal of child and adolescent psychopharmacology, 2013, Vol.23 (5), p.38-319
14.
Effects of clonidine and scopolamine on multiple target detection in rapid serial visual presentation
by Brown, S.B.R.E
Psychopharmacology, 2016, Vol.233 (2), p.341-350
15.
On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists
by Pattij, T
Psychopharmacology, 2012, Vol.219 (2), p.327-340
16.
Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats
by Bruijnzeel, Adrie W
Psychopharmacologia, 2010, Vol.212 (4), p.485-499
17.
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
by Aston-Jones, G
Nature (London), 2000, Vol.403 (6768), p.430-434
18.
The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain
by Alba-Delgado, Cristina
Psychopharmacologia, 2011, Vol.221 (1), p.53-65
19.
Clonidine restores vascular endothelial growth factor expression and improves tissue repair following severe trauma
by Loftus, Tyler J
The American journal of surgery, 2017, Vol.214 (4), p.610-615
20.
Ankle Joint Mobilization Affects Postoperative Pain Through Peripheral and Central Adenosine A1 Receptors
by Martins, Daniel F.
Physical therapy, 2013, Vol.93 (3), p.401-412
